WHO ICTRP trial

The safety and efficacy of intranasal ketamine delivery for sedation of children…

ACTRN12616000399493 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12616000399493
Public title The safety and efficacy of intranasal ketamine delivery for sedation of children in the emergency department. Is a needle-free approach to the care of children in the emergency department, practical and attainable?
Scientific title Ketamine Intranasal Delivery in the Emergency Room: A multicentre randomised controlled trial of Intranasal(IN) versus Intravenous(IV)/Intramuscular(IV) ketamine for paediatric sedation in the Emergency Department. Is a totally needle-free approach feasible?
Primary sponsor The Townsville Hospital and Health Service
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 2 / Phase 3
Countries Australia
Conditions Sedation procedures in children; Sedation procedures in children;Anaesthesiology - Other anaesthesiology
Interventions This is a comparative study of intranasal (spray inhaled through the nose) to intramuscular/intravenous (injection into the muscle or vein) delivery of ketamine to children for procedural sedation. Intranasal (N) IN ketamine 10mg/kg, should…
Registration date Mar 29, 2016
Target size 652
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations